Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

This lack of testing amplifies the misdiagnosis of RSV, as its symptoms are so similar to other, more common respiratory viruses like flu. A lack of recognition can also be seen in older adults ...

Researchers performed a retrospective case-control study using data from a large US healthcare network to evaluate the effectiveness of the RSVpreF vaccine in protecting older adults against RSV ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...

The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research. Researchers said the findings ...

Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t afford to pay $350 for a one-off vaccine.

Since 2023, vaccines are now available and are highly recommended, especially for older adults. Respiratory syncytial virus (RSV) is a common virus that causes mild to severe respiratory infections.

Doctor visits for RSV are at a "very high" level in Mississippi. Health officials provide warning signs of RSV to look for in ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...